Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss [Phase 3]

View source ↗

Summary

Phase 3 study evaluating tirzepatide (LY3298176) for the maintenance of weight loss in adults with obesity or overweight has completed, with results posted in M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2024-05-22